Oxidative stress in hypertension: mechanisms and therapeutic opportunities

R Brito1, G Castillo1, J González1

  • 1Laboratory of Oxidative Stress and Nephrotoxicity, Molecular and Clinical Pharmacology Program, Institute of Biomedical Sciences, Faculty of Medicine, University of Chile.

Insights

Oxidative stress, an imbalance of oxidants and antioxidants, plays a key role in hypertension and cardiovascular disease. Further research is needed to establish antioxidants as effective treatments for hypertension.

Area of Science:

  • Cardiovascular Science
  • Oxidative Stress Research
  • Pharmacology

Background:

  • Hypertension is a global health issue and a major risk factor for cardiovascular diseases like heart attack and stroke.
  • Oxidative stress, characterized by an imbalance between oxidants and antioxidants, is increasingly recognized as a central mechanism in hypertension.
  • The vascular wall is a significant source of reactive oxygen species (ROS), contributing to hypertension development.

Purpose of the Study:

  • To review the evidence linking oxidative stress to hypertension.
  • To highlight potential therapeutic targets for antioxidant therapy in hypertension management.
  • To explore the role of oxidative stress in the pathophysiology of hypertension.

Main Methods:

  • Review of existing scientific literature on oxidative stress and hypertension.
  • Analysis of studies investigating the sources and stimuli of reactive oxygen species in the vascular wall.
  • Examination of the impact of oxidative stress on vascular tone regulation.
  • Evaluation of the efficacy of antioxidant-based therapeutic strategies for hypertension.

Main Results:

  • Vascular sources of ROS include NADPH oxidase, xanthine oxidase, uncoupled eNOS, and mitochondrial dysfunction.
  • Vasoactive peptides like angiotensin II stimulate oxidative species production.
  • Oxidative stress reduces nitric oxide and prostacyclin bioavailability, impairing vascular tone.
  • Antioxidant therapies for hypertension have shown varied results, necessitating further investigation.

Conclusions:

  • Oxidative stress is a critical mediator in the development and progression of hypertension.
  • Understanding the mechanisms of oxidative stress provides targets for novel antihypertensive therapies.
  • Further research is essential to validate the role of antioxidants in effectively treating hypertension.

Related Concept Videos

Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
1.6K
Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
4.8K
Antihypertensive Drugs: Action of β1 Blockers01:17

Antihypertensive Drugs: Action of β1 Blockers

β1-receptors are primarily located in the heart and kidneys. In cardiac myocytes, these receptors interact with neurotransmitters released by the sympathetic nervous system during heightened activity or danger. As a result, β1-receptors get activated, initiating a series of biochemical processes. Excessive activation of beta receptors due to chronic stress can abnormally increase heart rate and contractility, resulting in high blood pressure or hypertension. To counteract this,...
2.3K
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
1.5K
Antihypertensive Drugs: Vasodilators01:23

Antihypertensive Drugs: Vasodilators

Vasodilators, primarily affecting the smooth muscles within arterial and venous walls, are commonly used for hypertension treatment. Medications such as minoxidil and hydralazine primarily target arteries and arterioles, while sodium nitroprusside acts on arterioles and venules. Minoxidil, functioning as a prodrug, is metabolized by hepatic sulfotransferase into its active form, minoxidil sulfate, after oral administration. This metabolite binds to the sulfonylurea receptor (SUR) component of...
2.5K
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors01:30

Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors

Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
2.9K